trending Market Intelligence /marketintelligence/en/news-insights/trending/pCk4vDSE2VvGZjOv7ZVjIA2 content esgSubNav
In This List

Zosano appoints board member

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Zosano appoints board member

Zosano Pharma Corp. appointed Kenneth Greathouse to its board of directors.

Greathouse is the co-founder and has served as CEO of Manchester Pharmaceuticals, which was sold to Retrophin Inc. in 2014.